Trusting yourself as a #leader is the first step toward others trusting you. Whether it's a new idea you've had for the future of #biotech, or a new workflow method for increased workplace #efficiency, have faith in your capabilities and others will too.

Just 2%. That’s the slice #WomenLedStartups get from the #VentureCapital pie. As a #FemaleFounder, I’ve felt the grind of pitching harder, proving more, and pushing uphill. We’re not short on ideas or talent, just access. It’s time to fund innovation equally. #EquityMatters

#Biotech funding in 2025 is hitting nearly $27B but is increasingly concentrated in fewer companies. Investors favor those with strong #ClinicalData, while early-stage and platform biotechs face funding challenges amid a more selective investment climate.

Big thanks to Dominic Forth + Thought Leaders America for having me on Momentum 50: Founders To Watch in 2025. Grateful to share the story behind Rise Above the Noise—and the “why” driving the work. 🎙️ #RiseAboveTheNoise #Momentum50 #Leadership #FoundersToWatch

25 years ago, non-invasive #CellTherapy for solid tumors sounded like sci-fi. Now? Moffitt & cTRL Therapeutics are making it real. Bold science and pragmatic development equals wins for patients AND the ecosystem. bizjournals.com/tampabay/news/…

In #biotech (and in life), your next opportunity isn’t always found in a pitch deck. It’s in the people you’re bold enough to meet. And that's something you can't automate or outsource... It's something you have to build person by person. American Thought Leaders 🇺🇸 with @JanJekielek

A lot of #BiotechStartups hit the same wall. Great science, no roadmap. That’s where DM Biotech Consulting steps in. We specialize in early-stage strategy for founders with big ideas and small budgets. Check out our site to learn more. #Biotech thedmconsulting.com/all-services

The FDA’s move to eliminate REMS for approved CAR T-cell therapies is a bold step toward democratizing access to potentially curative treatments. For #startups navigating this landscape, it’s a signal to think differently about how you’re enabling care. ajmc.com/view/fda-expan…

Most of the founders I work with are PhDs: visionary, highly skilled, and armed with game-changing ideas. But launching a #BiotechStartup is more than just a scientific challenge. That early phase? It’s messy. You need more than a breakthrough. You need a blueprint.

Innovation without clarity is just noise. If your organization, conference, or leadership summit is ready for a dose of real talk, I’m here for it. And if you’re more of a reader than a listener? My bestselling book #RiseAboveTheNoise is a great place to start.

The rules of the game have changed. Investors aren’t just betting on data; they’re betting on speed, positioning, and regulatory foresight. And in a climate where FDA timelines are shifting sand, that matters more than ever. #Biotech

This article on #StemCellTherapy for Crohn’s and ulcerative colitis caught my attention! It shows the field is finally catching up to a vision many of us have been pushing toward for years: regeneration over suppression. #Biotech medpagetoday.com/spotlight/ddw-…

Check out RiseAboveTheNoise’s Story! tiktok.com/t/ZPHtyUSvmFcB…